MichaelLloydWallaceMD
Pathology • Pittsburgh, PADermatopathology, Anatomic Pathology, Clinical Pathology
Physician
Dr. Wallace is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
522 Alpha Dr
Pittsburgh, PA 15238Phone+1 412-968-9266Fax+1 412-968-5673
Education & Training
Duke University HospitalFellowship, Dermatopathology, 1996 - 1997
Stanford Health Care-Sponsored Stanford UniversityResidency, Pathology-Anatomic and Clinical, 1993 - 1996
George Washington UniversityResidency, Surgery, 1992 - 1993
Johns Hopkins University School of MedicineInternship, Transitional Year, 1991 - 1992- George Washington University School of Medicine and Health SciencesClass of 1991
Certifications & Licensure
NY State Medical License 2017 - 2026
MD State Medical License 2001 - 2025
OH State Medical License 2019 - 2025
WV State Medical License 2001 - 2025
CA State Medical License 1993 - 2024
CT State Medical License 2022 - 2024
NC State Medical License 2005 - 2024- American Board of Pathology Anatomic Pathology
- American Board of Pathology Dermatopathology
- Join now to see all
Publications & Presentations
PubMed
- 31 citationsWidespread metastatic eccrine porocarcinoma.Rajat Goel, Melissa J. Contos, Michael L. Wallace
Journal of the American Academy of Dermatology. 2003-11-01 - 56 citationsEstrogen and progesterone receptors and anti-gross cystic disease fluid protein 15 (BRST-2) fail to distinguish metastatic breast carcinoma from eccrine neoplasms.Michael L. Wallace, Teri A. Longacre, Bruce R. Smoller
Modern Pathology. 1995-12-01 - 15 citationsRandomized Controlled Trial Evaluating a Standardized Strategy for Uveitis Etiologic Diagnosis (ULISSE).Christopher T. Leffler, Vikram S Brar, Michael L. Wallace
American Journal of Ophthalmology. 2017-07-01
Press Mentions
Editor’s Choice: The Emerging Role of Histologic Disease Activity Assessment in Ulcerative ColitisDecember 16th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
